Need of booster vaccine doses to counteract the emergence of SARS-CoV-2 variants in the context of the Omicron variant and increasing COVID-19 cases: An update

• Үндсэн зохиолчид: Ranjan K. Mohapatra (Зохиогч), Nahed A. El-Shall (Зохиогч), Ruchi Tiwari (Зохиогч), Firzan Nainu (Зохиогч), Venkataramana Kandi (Зохиогч), Ashish K. Sarangi (Зохиогч), Teroj Abdulrahman Mohammed (Зохиогч), Perumal Arumugam Desingu (Зохиогч), Chiranjib Chakraborty (Зохиогч), Kuldeep Dhama (Зохиогч)
• Формат: Ном
• Хэвлэсэн: Taylor & Francis Group, 2022-11-01T00:00:00Z.
• Нөхцлүүд: article
• Онлайн хандалт: Connect to this object online.

The emergence of different variants of SARS-CoV-2, including the Omicron (B.1.1.529) variant in November 2021, has resulted in a continuous major health concern at a global scale. Presently, the Omicron variant has spread very rapidly worldwide within a short time period. As the most mutated variant...